Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2026-02-18 @ 3:46 AM
Study NCT ID:
NCT06601127
Status:
RECRUITING
Last Update Posted:
2025-03-07
First Post:
2024-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).
Sponsor:
Tianjin Institute of Pharmaceutical Research Co., Ltd
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
TY601A-P2-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None